Patent · US Active

Recombinant proteins of parapdxvirus ovis and pharmaceutical compositions therefrom

US9714272B2 · kind B2 · utility

0Cited by

2References

11Claims

0Family size

Assignee

AiCuris GmbH & Co. KG · DE

Inventors

Olaf Weber · Wülfrath, DE
Sonja Maria TENNAGELS · Siegburg, DE
Angela Siegling · Brunn am Gebirge, AT
Tobias Schlapp · Goch, DE
Andrew Mercer · Dunedin, NZ
Stephen Bruce Fleming · Dunedin, NZ
Hans-Dieter Volk · Berlin, DE

Key dates

Filing date	Sep 8, 2014
Grant date	Jul 25, 2017
Priority date	—
Expiry date	Sep 8, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/24243
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.